|
|||||||||||||
| WELCOME | |||||||||||||
|
|
|
NanoDrugs is a new online only peer reviewed journal that accepts articles from all disciplines related to nanopharmacology and nanotoxicology. NanoDrugs applies the Creative Commons Attribution License (CCAL) to all manuscripts to be published. |
|
||||||||||
|
Introducing fair publication
at low cost 150 U$D publication fee |
NanoDrugs accepts different type of Articles
|
||||||||||||
|
NanoDrugs offers fast peer-review and publication. Corresponding authors will receive a notification within 72 hrs that his/her manuscript is accepted or not for revision. All original articles submitted to NanoDrugs should be prepared according our journal style and will be reviewed within one month.
You own the copyrights:
Authors who publish with
NanoDrugs agree to the following terms:
i). Authors retain copyright and grant
NanoDrugs
the right of first publication with the work simultaneously licensed under
a Creative Commons Attribution License that allows others to share the
work with an acknowledgement of the work's authorship and initial
publication in this journal. ii). Authors are able to enter into
separate, additional contractual arrangements for the non-exclusive
distribution of the journal's published version of the work (e.g., post it
to an institutional repository or publish it in a book), with an
acknowledgement of its initial publication in this journal. iii) Authors
are permitted and encouraged to post their work online (e.g. in
institutional repositories or on their website) prior to and during the
submission process, as it can lead to productive exchanges, as well as
earlier and greater citation of published work. Editorial Procedures All manuscript submitted to NanoDrugs are critically assessed by external and/or inhouse experts (One of our Editorial Board Member that has knowledge of the field discussed in the manuscript) in accordance with the principles of Peer Review http://www.icmje.org . This first step takes place entirely inhouse.
All manuscripts are sent for review. The reviewers will provide and extensive revision and a list of all critics authors need to address. If a manuscript does not receive a sufficiently high priority score to warrant publication, authors will be asked to provide a detailed resposne to all reviewers comments and resubmit their work within 3 month. In the second step, the articles are reviewed by at least one editor and one external referees.
The third step is the decision step by the Editor-In-Chief or and associate editor. |
|||||||||||||
|
|
|||||||||||||
|
|
|||||||||||||
